Kinnate Biopharma, Inc. (KNTE)

NASDAQ: KNTE · IEX Real-Time Price · USD
12.62
-0.38 (-2.92%)
Jun 29, 2022 4:00 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018
Selling, General & Admin
22.956.763.061.96
Research & Development
67.1729.248.965.68
Operating Expenses
90.113612.017.63
Operating Income
-90.11-36-12.01-7.63
Other Expense / Income
-0.35-0.24-0.040
Pretax Income
-89.76-35.76-11.97-7.63
Net Income
-89.76-35.76-11.97-7.63
Preferred Dividends
00-2.030
Net Income Common
-89.76-35.76-9.94-7.63
Shares Outstanding (Basic)
44744
Shares Outstanding (Diluted)
44744
Shares Change
544.26%84.93%0.30%-
EPS (Basic)
-2.06-5.28-2.72-2.09
EPS (Diluted)
-2.06-5.28-2.72-2.09
Free Cash Flow Per Share
-1.65-4.50-2.88-2.25
EBITDA
-89.64-35.68-11.97-7.63
Depreciation & Amortization
0.120.0800
EBIT
-89.76-35.76-11.97-7.63
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).